WARD 24/7 CSS App

Wireless Assessment of Respiratory and circulatory Distress (WARD) offers continuous 24/7 observation of high-risk patients with real-time alarms through innovative machine learning algorithms in a Clinical Support System (CSS).

What is WARD?


Wireless Assessment of Respiratory and circulatory Distress (WARD) is an innovative clinical support system founded in 2016. The WARD project integrates inputs from patient monitoring devices with intelligent algorithms to yield high-quality patient observation with real-time alarms triggered by patient vital sign deterioration.

Intended for use in several patient settings where the advantages and benefits of continuous monitoring may be fundamental. The WARD system has been used for monitoring in postoperative high-risk patients, in patients hospitalized with COPD, and in patients admitted with COVID-19 infection. 


WARD allows doctors and nurses to follow patients’ acute medical disease progression or postoperative course. The generation of real-time alarms will immediately alert relevant health care staff to allow initiation of treatment much earlier. Our well-designed, easy-to-use, and simple user interface offers health care professionals a valuable tool for overviewing current and historical vital signs. 


Daily routines of manual patient monitoring can be fundamentally changed to 24/7 observation of saturation, heart rate, respiration rate, blood pressure, etc. with alarms of important deviations. This may allow more efficient use of resources and the ability to give attention to the patients in special needs while at the same time keeping an eye on the remaining patients.



The WARD project will define, develop and implement the next generation monitoring system for high-risk patients, proving that it reduces complications and health care expenses. 

WARD Clinical Support System increase the quality of patient observation through continious and wireless monitoring of patient vital signs. Combining innovative technology with evidence-based algorithms, we allow earlier and more frequent detection of patient deteoriation through predictive AI-algorithms delivered in a user-friendly App.

Currently tested in all of Denmark’s Regions

Randomized Clinical Trial is taking place in 2020-2022 to test the efficiency of continious wireless monitoring of patient deteroriation and WARD App in all of the Danish Regions.

Initiation of the study is planned to take place in late 2020 and will include more than 1000 patients.


Recent News

Here you can see and read the latest highlights about WARD.


WARD staff are performing the last steps of customizing the unique WARD 24/7 CSS algorithm to support the App function.

Read More

Launch of WARD COVID-19 Study

Today we have launched the interim part of WARD COVID-19 study at several centres in the Capital Region of Denmark (Region Hovedstaden).

Read More

WARD Group Expands Study Reach

With the sudden outbreak of COVID-19 we are offering our assistance and devices to dedicated COVID-19 departments to take on a substantial part of…

Read More

Initiation of WARD-CGM

WARD Group initiates the WARD-CGM study leaded by Christian Carlsson, MD, PhD as primary investigator.

Read More

WARD Surgery Completes Patient Inclusion

The WARD Surgery study has today included its patient number 500 at Bispebjerg Hospital and finishes study inclusion. Congratulations to the entire WARD team…

Read More

WARD 24/7 CSS App Readies for Launch!

Final stages in the WARD 24/7 App development are underway and we expect to launch the App together with the initiation of medical and…

Read More


The Founders

Eske Kvanner Aasvang
MD, DMSc, Professor

Anesthesiological Department

Centre for Cancer and Organ Diseases ,


University of Copenhagen – Denmark

Christian Sylvest Meyhoff
MD, PhD, Professor

Department of Anaesthesia and Intensive Care,

Bispebjerg and Frederiksberg Hospital,
University of Copenhagen – Denmark

Helge Dissing Sørensen
MSc, PhD, Associate Professor
Department of Health Technology –
Technical University of Denmark (DTU) – Denmark

Contact WARD247